GSDMD and amyotrophic lateral sclerosis: In motor neuron diseases, studies have found that the expression level of the pyroptosis marker GSDMD is increased in spinal cord samples of amyotrophic lateral sclerosis (ALS) patients, indicating that microglial pyroptosis may play an important role in the pathogenesis of ALS (Van Schoor et al., 2022).